Skip to content

Examining the amount of pain and muscle atrophy visible in MRA of patients with non-specific chronic back pain before and after exercise therapy and corrective exercises in Imam Khomeini Hospital, Sari from 2022 to 2023

Examining the amount of pain and muscle atrophy visible in MRA of patients with non-specific chronic back pain before and after exercise therapy and corrective exercises in Imam Khomeini Hospital, Sari from 2022 to 2023

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221101056357N1
Enrollment
65
Registered
2022-12-05
Start date
2022-11-11
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back ache. Low back pain

Interventions

Intervention 1: Intervention group: The sports prescription and corrective movements will be 3 sessions per week for 3 months, which will be prescribed for the patients by a doctor of sports physiolog

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 50 Years

Inclusion criteria

Inclusion criteria: Non-specific chronic back pain patients Absence of spinal tumor Absence of spinal cord and spine infection No pregnancy Absence of spinal inflammatory lesions including AS and enthesopathies Lack of previous fracture caused by trauma or tumor Patients without history of spine surgery Absence of scoliosis more than 10 degrees, spinal canal stenosis Absence of spondylolisthesis Patients with psychosis or cognitive disorders in whom neurological examination is not reliable People who do not have MRI contraindications (phobia, pacemaker...) Patients do not have discopathy Patients with a history of metabolic and hormonal diseases, including acromegaly and hypothyroidism or hyperthyroidism. No diagnosed psychiatric illness such as mood disorders Does not have anxiety disorders, etc., and any neurological and muscular diseases such as dystrophies and other neurological disorders, including MS, ALS, etc.

Exclusion criteria

Exclusion criteria: Absence of more than 3 sessions Lack of consent to continue participating in the study The occurrence of damage during the study or the creation of a lesion after the start of treatment.

Design outcomes

Primary

MeasureTime frame
The amount of pain. Timepoint: Before starting the study and every week for 3 months. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajad Najafi

Mazandaran University of Medical Sciences

drsajjad_najafi@yahoo.com+98 11 3336 1630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026